Clinical Research Physician at Eli Lilly and Company

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Medical Doctor (MD) degree
Board eligible or certified in a medical specialty relevant to the role, or comparable level of post-medical school clinical training relevant to the country of hiring
For U.S. trained physicians: achieved board eligibility or certification
For foreign medical graduates in U.S. based jobs: may be hired at the discretion of the Chief Medical Officer if not U.S. board eligible or certified
For non-U.S. trained physicians: must have relevant qualifications (as specified in the job description)

Responsibilities

Provide medical oversight and strategic leadership throughout the clinical trial lifecycle, including design, planning, execution, and interpretation of trials for investigational compounds, ensuring patient safety and scientific integrity
Contribute to the design and development of key clinical documents, including study protocols, investigator’s brochures, informed consent documents, and other essential materials
Ensure the clinical development strategy adheres to industry best practices and regulatory guidelines while collaborating with study investigators and medical experts in the development and execution of study protocols
Lead the review and interpretation of clinical trial data, including safety assessments, efficacy endpoints, and overall trial progress
Serve as a key medical expert in cross-functional discussions, including regulatory submissions, investigator meetings, and advisory boards
Work with the Clinical Operations team to identify and resolve trial-related issues, ensuring smooth execution and compliance
Collaborate closely with the clinical operations, regulatory, and data management teams to ensure timely and high-quality execution of clinical trials
Collaborate with the research team to develop and implement a translational biomarker strategy for the program integrating early-phase data to inform clinical strategy
Contribute to regulatory submission efforts by providing clinical insight into IND submissions, clinical trial applications, and other regulatory documents; support responses to health authorities and ethics committees
Represent the company at scientific conferences, advisory boards, and meetings with regulatory authorities
Develop and maintain relationships with external stakeholders, including key opinion leaders (KOLs), clinical investigators, and contract research organizations (CROs)
Foster a collaborative and positive team environment that encourages innovation, scientific rigor, and high-performance standards
Travel to clinical sites, conferences, and regulatory meetings as needed
Other duties as assigned

Skills

Clinical Trials

Gene Editing

Medical Oversight

Protocol Design

Regulatory Compliance

Patient Safety

Biomarker Strategies

Strategic Leadership

Investigational Compounds

Cardiovascular Disease

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free